Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


J Am Soc Nephrol 15: 2249-2257, 2004
© 2004 American Society of Nephrology
doi: 10.1097/01.ASN.0000136778.32499.05

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verhulst, A.
Right arrow Articles by De Broe, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verhulst, A.
Right arrow Articles by De Broe, M. E.
J Am Soc Nephrol 15:2249-2257, 2004
© 2004 American Society of Nephrology


BASIC SCIENCE

Inhibitors of HMG-CoA Reductase Reduce Receptor-mediated Endocytosis in Human Kidney Proximal Tubular Cells

Anja Verhulst, Patrick C. D’Haese and Marc E. De Broe

Department of Nephrology-Hypertension, University of Antwerp, Belgium

Correspondence to Dr. Marc E. De Broe, University of Antwerp, Department of Nephrology-Hypertension, p/a Antwerp University Hospital, Wilrijkstraat 10, B-2650 Edegem / Antwerpen, Belgium. Phone: +32-3821-3421; Fax: +32-3829-0100;

ABSTRACT. The proximal tubular cells of the kidney are responsible for reabsorption of proteins from the tubular lumen. In a study using Opossum kidney (OK) cells, receptor-mediated protein endocytosis was reduced by statins, inhibitors of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase, which are widely used for therapeutic reduction of plasma cholesterol levels. To explore the possible clinical relevance of the observations in OK cells, protein endocytosis in human kidney tubular cells was investigated in the presence and absence of statins.

The uptake of FITC-labeled albumin in these cultures of human kidney tubular cells was investigated by microscopy, flow cytometry and spectrofluorometry. Protein uptake occurred selectively into proximal tubular cells while it was absent in distal tubular/collecting duct cells. Three statins (simvastatin, pravastatin, and rosuvastatin) significantly inhibited the uptake of protein in a concentration-dependent way. This inhibitory effect of statins could be prevented by the co-addition of mevalonate, the product of HMG-CoA reductase. This effect was not the result of a statin-induced cytotoxicity since cell-viability was unaffected. Finally, it was demonstrated that statins strongly inhibited cholesterol synthesis in the human kidney tubular cells.

These data suggest that statins have the potential to inhibit albumin uptake by the human proximal nephron as a result of inhibition of HMG-CoA reductase in the proximal tubule cells. Taken into account the data of the accompanying manuscript this inhibitory effect most probably results from a reduced prenylation of some proteins critically involved in endocytosis. It is suggested that these data help to explain the occurrence of proteinuria in some patients treated with high statin doses. E-mail: marc.debroe@ua.ac.be




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. Verhulst, R. Sayer, M. E. De Broe, P. C. D'Haese, and C. D. A. Brown
Human Proximal Tubular Epithelium Actively Secretes but Does Not Retain Rosuvastatin
Mol. Pharmacol., October 1, 2008; 74(4): 1084 - 1091.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
V. Cantaluppi, L. Biancone, G. M. Romanazzi, F. Figliolini, S. Beltramo, F. Galimi, M. G. Camboni, E. Deriu, P. Conaldi, A. Bottelli, et al.
Macrophage Stimulating Protein May Promote Tubular Regeneration after Acute Injury
J. Am. Soc. Nephrol., October 1, 2008; 19(10): 1904 - 1918.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
M. S. Kostapanos, H. J. Milionis, and M. S. Elisaf
An Overview of the Extra-Lipid Effects of Rosuvastatin
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2008; 13(3): 157 - 174.
[Abstract] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
M. S. Kostapanos, H. J. Milionis, V. G. Saougos, K. G. Lagos, C. Kostara, E. T. Bairaktari, and M. S. Elisaf
Dose-Dependent Effect of Rosuvastatin Treatment on Urinary Protein Excretion
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2007; 12(4): 292 - 297.
[Abstract] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Diwakar, A. L. Pearson, P. Colville-Nash, N. J. Brunskill, and M. E. C. Dockrell
The role played by endocytosis in albumin-induced secretion of TGF-beta1 by proximal tubular epithelial cells
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1464 - F1470.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. H. Brantsma, J. Atthobari, S. J.L. Bakker, D. de Zeeuw, P. E. de Jong, R. T. Gansevoort, and for the PREVEND Study Group
What Predicts Progression and Regression of Urinary Albumin Excretion in the Nondiabetic Population?
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 637 - 645.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Atthobari, A. H. Brantsma, R. T. Gansevoort, S. T. Visser, F. W. Asselbergs, W. H. van Gilst, P. E. de Jong, L. T. W. de Jong-van den Berg, and on behalf of PREVEND study group
The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study
Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3106 - 3114.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
M. S. Kostapanos, H. J. Milionis, I. Gazi, C. Kostara, E. T. Bairaktari, and M. Elisaf
Rosuvastatin Increases {alpha}-1 Microglobulin Urinary Excretion in Patients With Primary Dyslipidemia.
J. Clin. Pharmacol., November 1, 2006; 46(11): 1337 - 1343.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. D'Amico
Statins and Renal Diseases: From Primary Prevention to Renal Replacement Therapy.
J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S148 - S152.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. E. Sidaway, R. G. Davidson, F. McTaggart, T. C. Orton, R. C. Scott, G. J. Smith, and N. J. Brunskill
Inhibitors of 3-Hydroxy-3-Methylglutaryl-CoA Reductase Reduce Receptor-Mediated Endocytosis in Opossum Kidney Cells
J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2258 - 2265.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Agarwal
Statin Induced Proteinuria: Renal Injury or Renoprotection?
J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2502 - 2503.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP